MarginsXMarginsX
Home › Markets › Health Care › CSTL

Castle Biosciences Inc. (CSTL)

CSTL trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$32.75
-3.08% on the day
Market cap
$1.0B
Small cap
Revenue · 2025
$344.2M
+3.7% on 2024
Net income · 2025
-$24.2M
-7.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1447362/000162828026012272/0001628280-26-012272-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCSTL on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO year2019
SEC CIK0001447362
SEC industry codeServices-Medical Laboratories
Incorporated inDE

Financials · 2025

LineValue
Revenue$344.2M
Net income-$24.2M
Operating income-$42.8M
Net margin-7.0%
Operating margin-12.4%
Revenue growth+3.7%
Cash$116.7M
Total assets$578.6M
P/E (computed)Net income was not positive
P/S (computed)2.9×

Warning signs

Cash runway
Cash-flow positive
$78.0M cash at September 30, 2026
Share count, 1 year
+5.6%
2025-10-27 to 2026-10-29 · +14.5% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$17.8M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$78.0M cash; operating cash flow $9.9M a quarter.Report 2026-09-30
Shares outstanding30,818,291 (2026-10-29); 29,188,659 a year earlier; 26,910,548 three years earlier.Cover page 2026-10-29
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorKPMG LLP, Houston, Texas, United StatesPCAOB Form AP 2026-03-25
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $17.8M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$102.9M-$4.1M$19.7M$78.0M$10.1M$377.1M10-Q 2026-11-05
Q2 2026
2026-06-30
$103.5M-$2.1M$15.2M$62.1M$10.1M$357.3M10-Q 2026-07-30
Q1 2026
2026-03-31
$83.7M-$14.5M-$22.1M$63.8M$10.1M$339.9M10-Q 2026-05-06
Q4 2025
2025-12-31
$87.0M-$2.3M$26.9M$116.7M$10.1M$344.2M10-K 2026-02-26
Q3 2025
2025-09-30
$83.0M-$501K$22.6M$85.6M$10.0M$343.5M10-Q 2026-11-05
Q2 2025
2025-06-30
$86.2M$4.5M$20.8M$82.2M$10.0M$346.3M10-Q 2026-07-30
Q1 2025
2025-03-31
$88.0M-$25.8M-$6.0M$89.7M$10.0M$347.1M10-Q 2026-05-06
Q4 2024
2024-12-31
$86.3M$9.6M$24.4M$119.7M$10.0M$332.1M10-K 2026-02-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32024-02-28
Latest annual report10-K2026-02-26
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-05
Latest proxyDEFA14A2026-04-08

Source: SEC EDGAR submissions feed, 894 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+3.9%
1 month+2.8%
3 months+10.6%
Year to date-13.1%
1 year-1.0%
From 52-week high-21.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
FRNMFreenome Inc.$10.09-3.07%$1.1B
LMRILumexa Imaging Holdings Inc.$14.79-0.14%$1.4B
FLGTFulgent Genetics Inc.$24.07-2.37%$672.6M
ALHCAlignment Healthcare Inc.$7.47+1.49%$1.6B
TRUPTrupanion Inc.$36.16+4.87%$1.6B
PSNLPersonalis Inc.$14.80-5.79%$1.6B
FTREFortrea Holdings Inc.$19.79-2.03%$1.9B
VCYTVeracyte Inc.$24.01-1.32%$1.9B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier